bioAffinity Technologies, Inc. Operating Costs and Expenses
bioAffinity Technologies, Inc. (BIAF) reported Operating Costs and Expenses of $1.09 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingCostsAndExpenses · last filed 2026-08-07
- bioAffinity Technologies, Inc. operating costs and expenses for the quarter ending 2026-06-30 was $1.09M, a 7.01% increase year-over-year.
- bioAffinity Technologies, Inc. operating costs and expenses for the quarter ending 2026-03-31 was $928.64K, a 32.11% decline year-over-year.
- bioAffinity Technologies, Inc. operating costs and expenses for the quarter ending 2025-06-30 was $1.02M.
- bioAffinity Technologies, Inc. operating costs and expenses for the quarter ending 2025-03-31 was $1.37M.
| Period end | Operating Costs and Expenses 3 month | Operating Costs and Expenses 6 month |
|---|---|---|
| 2026-06-30 | $1.09M 10-Q · filed 2026-08-07 | $2.02M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $928.64K 10-Q · filed 2026-05-11 | |
| 2025-06-30 | $1.02M 10-Q · filed 2026-08-07 | $2.38M 10-Q · filed 2026-08-07 |
| 2025-03-31 | $1.37M 10-Q · filed 2026-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |